Cory Randall Ellspermann - 04 Aug 2025 Form 3 Insider Report for Inmune Bio, Inc. (INMB)

Role
Interim CFO
Signature
/s/ CORY RANDALL ELLSPERMANN
Issuer symbol
INMB
Transactions as of
04 Aug 2025
Net transactions value
$0
Form type
3
Filing time
18 Aug 2025, 18:22:45 UTC
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ellspermann Cory Randall Interim CFO C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON /s/ CORY RANDALL ELLSPERMANN 18 Aug 2025 0002082083

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INMB Stock Options 04 Aug 2025 Common Stock 75,000 $3.91 Direct F1
holding INMB Stock Options 04 Aug 2025 Common Stock 40,000 $21.06 Direct F1
holding INMB Stock Options 04 Aug 2025 Common Stock 30,000 $7.92 Direct F1
holding INMB Stock Options 04 Aug 2025 Common Stock 30,000 $9.92 Direct F2
holding INMB Stock Options 04 Aug 2025 Common Stock 70,000 $5.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.
F2 The option vested or vests as to one-forty-eighth (1/48) of the total award monthly, with the first tranche vesting on June 14, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the Reporting Person's continued service with the Issuer on each vesting date.
F3 The option vests and becomes exercisable on December 5, 2026, subject to the Reporting Person's continued service with the Issuer on the vesting date.